Connect Biopharma Limite... (CNTB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.00
-0.01 (-0.99%)
At close: Jan 28, 2025, 2:14 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
PE Ratio | -1.09 | -0.41 | -1.31 | -8.29 | -42.96 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.64 | -0.1 | 0.99 | -6.35 | -23.85 | n/a |
P/FCF Ratio | -1.35 | -0.46 | -2.89 | -35.68 | -77.89 | n/a |
P/OCF Ratio | -1.36 | -0.48 | -3.15 | -38.95 | -78.82 | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 | -4.52 |
Quick Ratio | 4.99 | 10.37 | 15.30 | 26.97 | 12.44 | 70.44 |
Current Ratio | 4.99 | 9.97 | 15.30 | 27.81 | 13.24 | 70.44 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -5.59K | -14.35K | -4.71K | -2.08K | n/a |
Return on Equity (ROE) | -0.59 | 0.25 | -0.75 | 0.77 | 0.56 | n/a |
Return on Assets (ROA) | -0.47 | -0.66 | -0.7 | -0.72 | -0.44 | n/a |
Return on Capital (ROIC) | -0.61 | -0.73 | -0.36 | -0.19 | -0.32 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |